Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Biogen	BIIB	Healthcare \| Biotechnology	77	15.4%

Current Price (09/20)			$238.79
CAPS Rating (Rate this stock on CAPS)

Expected Income Statement
Current Sales			13,886.8
Sales Growth Forecast			6.9%
Net Profit Margin			37.8%

Projected Shares Outstanding			180.08
EPS - Five year Forecast			$40.64
Average P/E Ratio			12.0
Projected Average Price			$487.70

Price Appreciation (Annualized)			15.4%
Annual Dividend Yield			0.0%
Projected Annual Return			15.4%

Quality
Financial Strength			84	21.0
EPS Stability			74	18.5
Industry Sales Growth Rate			16.5%	5.2
Industry Net Profit Margin			29.0%	16.3
Calculated Quality Rating			61.0

Fool CAPS
Total Players 992 Outperforms 71 Underperforms All-Stars (243) 231 Outperforms (95%) 12 Underperforms

Fundamental Data Updated: 07/05/2019

MIPAR	8.8%
Sweet Spot	13.8% - 18.8%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 13.8%-18.8%
Yellow	PAR is above the target range of MIPAR +10%, currently 18.8%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.